Topic: BIOMARKERS IN MS

Use of neurofilament-light chain (NfL) in the management of patients with multiple sclerosis

June 27, 2024  

New guidance on use of sNfL in practice

May 27, 2024  

REPORT FROM AAN 2024 – MONDAY, APRIL 15

April 15, 2024  

Fluid biomarkers: theory and practice

March 18, 2024  

New consensus statement on MRI biomarkers in MS

February 20, 2024  

McDonald criteria 2024: what changes can we expect?

January 30, 2024  

NfL a marker of microglial activation

December 6, 2023  

Biomarkers after stopping treatment may identify at-risk MS patients

November 30, 2023  

Neurofilament-light chain (NfL) as a biomarker of response to higher-efficacy disease-modifying therapies

November 22, 2023  

OCT – diagnosis and prognosis

November 8, 2023